Wildon Farwell, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 2,666 shares at $10.72 ($28K) on 2023-12-11, disclosed to the SEC on 2023-12-12.
Scheduled sale ($28k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.72 | 1,688 | $18K | 63.7% |
| 2 | $10.55 | 978 | $10K | 36.3% |
| Total | $10.66 avg | 2,666 | $28K | 100% |
| Filing → |
| DYN | SELL | 2024-05-17 | $122K | — | Filing → |
| DYN | SELL | 2024-03-12 | $67K | — | Filing → |
| DYN | SELL | 2024-03-11 | $472K | — | Filing → |